Stockscreener 앱 받기
2.03
0.50%
0.010
시간 외 거래:
2.00
-0.03
-1.48%
전일 마감가:
$2.02
열려 있는:
$2.04
하루 거래량:
506.20K
Relative Volume:
0.80
시가총액:
$294.29M
수익:
$28.94M
순이익/손실:
$-54.29M
주가수익비율:
-4.3684
EPS:
-0.4647
순현금흐름:
$-26.02M
1주 성능:
-14.71%
1개월 성능:
-6.88%
6개월 성능:
-1.46%
1년 성능:
+19.41%
1일 변동 폭
$2.00
$2.125
1주일 범위
$2.00
$2.47
52주 변동 폭
$1.30
$2.79
Omniab Inc Stock (OABI) Company Profile
명칭
Omniab Inc
전화
510-250-7800
주소
5980 HORTON STREET, EMERYVILLE
Compare OABI vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
2.03 | 305.89M | 28.94M | -54.29M | -26.02M | -0.4647 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-04-21 | 개시 | The Benchmark Company | Buy |
| 2023-04-13 | 개시 | Craig Hallum | Buy |
| 2023-02-22 | 개시 | Cowen | Outperform |
| 2023-02-13 | 개시 | H.C. Wainwright | Buy |
| 2022-12-20 | 개시 | Truist | Buy |
| 2022-12-16 | 개시 | Credit Suisse | Outperform |
| 2022-11-29 | 개시 | SVB Leerink | Outperform |
| 2022-11-28 | 개시 | Stifel | Buy |
모두보기
Omniab Inc 주식(OABI)의 최신 뉴스
OABI Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SentimentAnalyst Consensus Shift - newsline.com
OmniAb, Inc. Hits New 52-Week High of $2.79 Amidst Market Challenges - Markets Mojo
Companies Like OmniAb (NASDAQ:OABI) Are In A Position To Invest In Growth - Yahoo Finance
OmniAb Inc. (OABI) Gains 3.26% as Stock Approaches Key Resistance LevelAnalyst Upgrade Stocks - newsline.com
OABI Stock Price, Quote & Chart | OMNIAB INC (NASDAQ:OABI) - ChartMill
OmniAb Inc. (OABI) Edges Lower as Stock Nears Key Support ZoneFibonacci Retracement - newsline.com
OmniAb (OABI) Hovers Near Key Support After Slight DeclineRunaway Gap - The Legal Advocate
OABI Q1 2026 Earnings: EPS Beat Masks Ongoing R&D InvestmentsUpward Estimate Revision - newsline.com
OABI Q1 2026 Earnings: Wider-than-Expected Loss Narrows as EPS Surprises PositivelyEarnings Yield Spread - newsline.com
OmniAb, Inc. Hits New 52-Week High at USD 2.73 - Markets Mojo
OmniAb Stock Is Back Near Its High — Why OABI’s Next Few Days Matter - Bez Kabli
OmniAb Inc. (OABI) Gains 3.92% as Stock Approaches Key Resistance at $2.78Narrow Range Breakout - newsline.com
OmniAb Inc. (OABI) Shares Edge Higher as Key Support HoldsOn Balance Volume - thelegaladvocate.com
OmniAb Inc. (OABI) Rallies 3.9% as Stock Tests Key Resistance LevelsLinear Regression - The Legal Advocate
Is OmniAb Positioned To Be A Long-Term Biotech Winner? - RTTNews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Sahm
OmniAb, Inc. Common Stock OABI ) Stock Price Today & Analysis - Gotrade
OmniAb unveils OmniUltra in vivo platform at TIDES USA event - Traders Union
OmniAb, Inc. (OABI) reports Q1 loss, tops revenue estimates - MSN
We're Hopeful That OmniAb (NASDAQ:OABI) Will Use Its Cash Wisely - Moomoo
TradingKey - TradingKey
OmniAb forecasts $28M-$33M 2026 revenue as partner milestones lift outlook - MSN
OmniAb, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:OABI) 2026-05-11 - Seeking Alpha
Number of shareholders of OmniAb, Inc. – NASDAQ:OABIW - TradingView
OmniAb (NASDAQ:OABI) Issues Earnings Results - MarketBeat
OmniAb Reports Strong Revenue Growth Driven by Clinical Partner Progress - HarianBasis.co
OmniAb, Inc. (NASDAQ:OABI) Q1 2026 Earnings Call Transcript - Insider Monkey
OmniAb (OABI) FY 2025 Loss Of US$64.8m Keeps Profitability Narrative Under Pressure - Sahm
OmniAb Earnings Call Highlights Surge In Milestones - TipRanks
OmniAb’s Q1 2026 Revenue Rises to $25.3 Million, Net Loss Decreases - geneonline.com
OmniAb unveils in vivo platform for human antibody and peptide discovery at 2026 PEGS Summit - Traders Union
OmniAb (OABI) Q1 2026 Earnings Transcript - AOL.com
Craig-Hallum Maintains OmniAb(OABI.US) With Buy Rating, Announces Target Price $7 - Moomoo
OmniAb, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
OmniAb Q1 2026 slides: revenue surges 243%, guidance raised By Investing.com - Investing.com Australia
OmniAb Q1 Earnings Call Highlights - MarketBeat
TD Cowen Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $3 - Moomoo
H.C. Wainwright Maintains OmniAb(OABI.US) With Buy Rating, Maintains Target Price $11 - Moomoo
The organic vs inorganic growth story at OmniAb (OABI) | Q1 2026: EPS Beats ForecastsAI Stock Signals - newser.com
OmniAb Reports First Quarter 2026 Financial Results and Business Highlights - BioSpace
OmniAb, Inc. (OABI) Reports Q1 Loss, Tops Revenue Estimates - Yahoo! Finance Canada
Earnings call transcript: OmniAb Q1 2026 sees revenue surge, stock climbs - Investing.com
Omniab Inc (OABI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Omniab Inc 주식 (OABI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| FOEHR MATTHEW W | President and CEO |
Apr 07 '26 |
Option Exercise |
0.00 |
36,459 |
0 |
4,439,736 |
| FOEHR MATTHEW W | President and CEO |
Apr 07 '26 |
Sale |
1.49 |
19,244 |
28,674 |
4,420,492 |
2.60%
0.94%
자본화:
|
볼륨(24시간):